Advanced Enzyme

Advanced Enzyme Technologies slips 12% on disappointing Q2 results

The specialty biotech company's Ebitda declined 17 per cent annually to Rs 42 crore, while margins contracted 346 bps to 29 per cent during the quarter

Bio-E3 policy to bring bio-revolution in India, says Jitendra Singh

The government's Bio-E3 policy marks a crucial step in positioning India as a global bio-economy leader and is set to spark a "bio-revolution" in India similar to the IT revolution in the western world, Union minister Jitendra Singh said on Thursday. The BioE3 policy was formally launched last month and aims to facilitate sustainable and efficient utilisation of biological resources for innovation, scaling-up and bio-manufacturing of specialty chemicals, enzymes, bio-polymers, functional foods, smart proteins, veterinary products, precision bio-therapeutics and services. Speaking at the Global Bio-India Summit 2024, Singh said the policy marks a crucial step in positioning India as a global bio-economy leader. The Minister of State (Independent Charge) for Science and Technology also highlighted the importance of the Global Biotech platform, which brings together a diverse range of stakeholders, including start ups, SMEs, large industries, research institutes, and international ...

Advanced Enzyme public offering subscribed 115 times

3.2-million share offering received 373 mn bids

Advanced Enzyme subscribed four times on Day 2

The company has already raised Rs 123 cr from 15 anchor investors, by allotting them shares at Rs 896 apeice

Advanced Enzyme subscribed 75% on Day One

The company on Tuesday raised Rs 123 cr from 15 anchor investors, which included DB International, Kuwait Investment Authority and DSP Blackrock Equity

Advanced Enzyme raises Rs 123 cr from underwriters

The company's Rs 412-crore IPO will remain open between Wednesday and Friday

Enzyme's IPO to open on July 20

The IPO price band has been set at Rs 890-896 per share